Intrapericardial instillation of mitoxantrone in palliative therapy of malignant pericardial effusion

Onkologie

Volumn 26, Issue 2, 2003, Pages 135-139

  Musch, Eugen ^a   Gremmler, B ^a   Nitsch, J ^b   Rieger, J ^c   Malek, M ^d   Chrissafidou, A ^d  

^a Marien Hospital Bottrop gGmbH   (Germany)

^b St Agnes Hospital Bocholt gGmbH   (Germany)

^c Innere Medizin   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Intrapericardial instillation; Malignant pericardial effusion; Mitoxantrone

Indexed keywords

MITOXANTRONE;

ADULT; AGED; ALOPECIA; ANOREXIA; ARTICLE; BREAST CARCINOMA; BRONCHUS CANCER; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DRUG EFFECT; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; FEVER; FOLLOW UP; HEART METASTASIS; HUMAN; LEUKOPENIA; MALE; NAUSEA; PAIN; PERICARDIAL EFFUSION; SIDE EFFECT; STOMACH ADENOCARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART NEOPLASMS; HUMANS; INSTILLATION, DRUG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOXANTRONE; PALLIATIVE CARE; PERICARDIAL EFFUSION; PERICARDIUM; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 0038653508     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069833     Document Type: Article

References (30)

1. DeVita VR, Hellman S, Rosenberg SA: Pericardial effusions; in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer (ed 4), Philadelphia, Lippincott Williams & Wilkins, 1993, pp 2251-2255.
2. Hancock EW: Neoplastic pericardial disease. Cardiol Clin 1990;8:673-682.
3. Vaitkus PT, Herrmann H, LeWinter M: Treatment of malignant pericardial effusion. JAMA 1994;272:59-64.
4. Martinoni A, Cipolla CM, Civelli M, Cardinale D, Lamantia G, Colleoni M, DeBraud F, Susini G, Martinelli G, Goldhirsh A, Fiorentini C: Intrapericardial treatment of neoplastic pericardial effusions. Herz 2000;8:787-793.
5. Traganos F, Evenson DP, Staiano-Coico L, Drazynkiewicz Z, Melamed MR: Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells. Cancer Res 1980;40:671-681.
6. Ehninger G, Günther E, Proksch B, Blöchl-Daum E, Rainer H, Aapro M: Intrakavitäre Therapie mit Mitoxantron: Eine pharmakokinetische Auswertung; in Seeber S, Aigner KR, Enghofer E (Hrsg): Onkologisches Kolloquium 2: Die lokoregionale Tumortherapie. Berlin, de Gruyter, 1988, pp 23-27.
7. Musch E, Paar WD, Hoffmann B, Seitzer D, Chemaissani A, Bode U, Werner A, Peiss J, Mackes KG, Hartlapp HJ, Eberhard K: Intrapleurale Instillation von Mitoxantron zur Palliativ-Therapie maligner Pleuraergüsse. Tumor Diag Ther 1989;10:64-71.
8. O'Bryan RM, Talley RW, Brennan MJ, San Diego E: Critical analysis of the control of malginant effusion with radioisotopes. Henry Ford Hosp Med J 1968;16:3-34.
9. Celermajer DS, Boyer MJ, Bailey BP, Tattersall MH: Pericardiocentesis for symptomatic malignant pericardial effusion: A study of 36 patients. Med J Aust 1991;154:19-22.
10. Maher EA, Sheperd FA, Todd TJR: Pericardial sclerosis as the primary management of malignant effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996;112:637-643.
11. Davis S, Rambotti P, Grignani F: Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: An analysis of thirty-three cases. J Clin Oncol 1984;2:631-636.
12. Markiewicz W, Lashevsky I, Rinkevich D, Teitelman U, Reisner SA: The acute effect of minocycline on the pericardium: Experimental and clinical findings. Chest 1998;113:861-866.
13. Lashevsky I, Ben Yosef R, Rinkevich D, Reisner S, Markiewicz W: Intrapericardial minocycline sclerosis for malignant pericardial effusion. Chest 1996; 109:1452-1454.
14. Liu G, Crump M, Goss PE, Dancey J, Shepherd FA: Prospective comparison of the sclerosis agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol 1996;14:3141-3147.
15. Yano T, Yokoyama H, Inoue T, Takanashi N, Asoh H, Ichinose Y: A simple technique to manage malignant pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology 1994;51:507-509.
16. van Belle SJ, Volckaert A, Taeymans Y, Spapen H, Block P: Treatment of malignant pericardial tamponade with sclerosis induced by instillation of bleomycin. Int J Cardiol 1987;16:155-160.
17. Tomkowski WZ, Filipechi S: Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. Lung Cancer 1997;16:215-222.
18. Bishiniotis TS, Antoniadou S, Katseas G, Mouratidou D, Litos AG, Balamoutsos N: Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of tiethylenethiophosphoramide (thiotepa). Am J Cardiol 2000;86:362-364.
19. Colleoni M, Martinelli G, Beretta F, Marone C, Gallino A, Fontana M, Graffeo R, Zampino G, De Pas T, Cipolla G, Martinoni C, Goldhirsch A: Intra-cavitary chemotherapy with thiotepa in malignant pericardial effusions: An active and well-tolerated regimen. J Clin Oncol 1998;16:2371-2376.
20. Girardi LN, Ginsberg RJ, Burt ME: Pericardiocentesis and intrapericardial sclerosis: Effective therapy for malignant pericardial effusions. Ann Thorac Surg 1997;64:1422-1428.
21. Norum J, Lunde P, Aasebo U, Himmelmann A: Mitoxantrone in malignant pericardial effusion. J Chemother 1998;10:399-404.
22. Lentsch S, Reichardt P, Gürtler R, Dörken B: Intrapericardial application of mitoxantrone for treatment of malignant pericardial effusion. Onkologie 1994;17:504-507.
23. Hoffmann W, Reichel H, Schiebe M, Bültmann B, Bamberg M: Intrapericardial instillation of mitoxantrone in malignant pericarditis: Histomorphological appearance. Reg Cancer Treat 1993;2:91-93.
24. Ammon J, Icking D, Sigmund M, Zimmermann U: Intraperikardiale Instillation von Mitoxantron bei malignen Perikardergüssen; in Musch E, Dietel M, Schenk S (Hrsg): Aktuelle Onkologie 54. München, Zuckschwerdt, 1990, pp 70-84.
25. Schroeder M, Drobig C, Neumann G, Westerhausen M: Palliation of malignant pericardial effusion by intrapericardial mitoxantrone. Blut 1989; 59:259 (abstr 58).
26. Kuhn K, Purea H, Selbach J, Westerhausen M: Treatment with locally applied mitoxantrone. Acta Med Austriaca 1989;16:87-90.
27. Landys K, Risenfors M: Intrapericardial mitoxantrone for palliation of cardiac tamponade due to cancer metastasis; Workshop: Progress in Regional Cancer Therapy I, Wien, 1988, pp 152 (abstr 264).
28. Ehninger G, Proksch B, Heinzel G, Schiller E, Weible KH, Woodward DL: The pharmacokinetics and metabolism of mitoxantrone in man. Invest New Drugs 1985;3:109-116.
29. Kaufmann M, Schmid H, Kubli F: Intraperitoneale Mitoxantron-Applikation beim progredienten Ovarialkarzinom mit Aszitesbildung; in Seeber S, Aigner KR, Enghofer E (Hrsg): Onkologisches Kolloquium 2: Die lokoregionale Tumortherapie. Berlin, de Gruyter, 1988, pp 61-70.
30. Dietel M: Intrapleurale Mitoxantron-Applikation bei Mammakarzinom: Zytologie, in-vitro-Chemosensitivität, klinischer Verlauf. Lecture IV. Int Conf Adv Regional Cancer Therapy, Berchtesgaden 1989.